Clinical Trials Directory

Trials / Terminated

TerminatedNCT01576679

Safety and Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-Abdominal Collections in Children - A Prospective Study

A Double Blind, Randomized Controlled Trial Examining the Efficacy of the Use of Tissue Plasminogen Activator (tPA) in Intra-abdominal Collections in Children - a Prospective Study

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
28 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to establish the efficacy of tPA when used in pediatric intra-abdominal abscesses immediately after percutaneous drainage, irrespective of the ultrasound appearance or consistency of the drained fluid.

Detailed description

The use of tPA in pediatric abdominal abscesses is poorly defined. The indications are somewhat subjective and the dosage guidelines vary between institutions. Some studies have suggested that it be administered at, or soon after, the time of drainage if the ultrasound appearance of the collection is complex and/or septated, or if the initial aspirated contents are thick and viscous. Both criteria are difficult to accurately define and implement. In many instances, when there is minimal ongoing drainage despite follow-up ultrasound appearances suggesting a significant residual collection, tPA is administered several days following the initial procedure. The purpose of this study is to establish the efficacy of tPA in the initial treatment of all pediatric intra-abdominal abcesses and a standardized manner in which it can be used. This may eventually lead to a change in practice in the management of this patient population.

Conditions

Interventions

TypeNameDescription
DRUGCathflo (Alteplase)
DRUGSaline

Timeline

Start date
2012-03-01
Primary completion
2016-05-01
Completion
2017-06-01
First posted
2012-04-12
Last updated
2019-06-27

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01576679. Inclusion in this directory is not an endorsement.